Menu
Log in



Your Resource for Neurotherapeutics Discovery and Development


  • Home
  • Annual Meeting

2024 Annual Meeting Overview

ASENT 2024 ADVANCE PROGRAM BOOK HOTEL ABSTRACT SUBMISSION MEETING REGISTRATION 

2025 CALL FOR TOPICS 

Join us as the American Society for Experimental Neurotherapeutics Annual Meeting (ASENT 2024) returns to in person at the Hyatt Regency Bethesda, in Bethesda, MD from March 12-14, 2024. 

ASENT's 2024 Annual Meeting is the premier neuroscience and neurotherapeutics conference where senior leaders from healthcare payers, providers and prescribers, employers, investors, fast-growing startups, big pharma, policymakers, funders and innovation centers gather to improve the process of bringing neurotherapeutics to market.

The Meeting features nine symposia, which address therapeutic advances in a broad range neurologic disease states, processes and delivery methods; as well as interactive poster presentations, ASENT's celebrated pipeline presentations, and live discussion with speakers at the end of each day. 

Meeting Highlights 

    • FIRESIDE CHAT: Preclinical to First in Human in Neurotherapeutic Drug Development
    • SYMPOSIA ON THE FOLLOWING:
    • Platform Clinical Trials in Neurology
    • Exosome in Neurotherapeutics
    • Digital Biomarkers in CNS Clinical Studies
    • Opportunities to streamline development of gene therapies for rare diseases
    • Current research and Advances in Multiple Sclerosis
    • Parkinson's disease biological staging and implications for therapeutic trials
    • Fluid Biomarkers as endpoints for neurodegenerative diseases
    • Animal Models in Neurotherapeutics: the good, the bad and the ugly.
    • Novel Delivery Systems in CNS
    • LATEST DATA: Covid CNS Update
    • DEBATE: Beta Amyloid Debate
    • CNS PIPELINE Presentations
    • CAREER DINNER Featuring Guest Speakers
    • NEUROTHERAPEUTICS DINNER Featuring Guest Speakers
    • Interactive Poster Discussions
    • Live Discussions in Breakout Rooms with Speakers

    • And much, much more!

    Meeting Location
    Hyatt Regency Bethesda, Bethesda MD

    RESERVE YOUR ROOM

    Who Attends

    50% of attendees are practicing physicians| Physician-Scientists | Neurologists | Neuroscientists | Drug and Device Companies | Fellows | Post-docs | Founders | Funders | Industry Leaders | Nonprofit Organizations and Advocacy Groups | Journal Editors | Representatives from NIH, NIA, NIDA, NINDS and FDA

    The 2024 meeting will feature a high number of junior faculty and trainees as attendees at our clinical trials course and neurotherapeutic drug discovery course are welcome to attend the annual meeting at no cost. 

    Neurology students and residents interested in neurotherapeutic development will benefit from the insight of senior investigators and leaders in industry, while private practice neurologists considering entering the clinical trial space will benefit from lessons learned by ASENT leadership. The Annual Meeting features career development sessions that offer strategies for achieving professional success in the field of neurotherapeutics. 


    Upcoming events

      • March 12, 2024
      • 8:00 AM
      • March 14, 2024
      • 1:00 PM
      • Hyatt Regency Bethesda, Bethesda, MD
      Register

      ABOUT ASENT 2024 Annual Meeting

      The ASENT 2024 Annual Meeting, which will take place March 12 - 14, 2024 at the Hyatt Regency Bethesda in Bethesda, MD, is the premier neuroscience and neurotherapeutics conference where senior leaders from leading payers, providers, employers, investors, fast-growing startups, pharma, policymakers, funders and innovation centers gather with one central focus, improving the process of bringing neurotherapeutics to market.

      The plenary sessions, panel discussions, outstanding pipeline presentations and poster sessions focus on the latest science in neurotherapeutics. The conference content will focus on the latest science in neurotherapeutics including innovations across disease states, novel delivery systems, gene therapy and biomarkers, and of course the latest drug therapies and devices. The event features plenary sessions, panel discussions, satellite luncheons, networking meetings, pipeline presentations and poster sessions.

      WHO ATTENDS

      Physician-Scientists | Neurologists | Neuroscientists | Trainees | Drug and Device Companies | Fellows | Post-docs | Founders | Funders | Industry Leaders | Nonprofit Organizations and Advocacy Groups | Journal Editors | Representatives from NIH, NIA, NIDA, NINDS and FDA


    Powered by Wild Apricot Membership Software